Almodovar Diaz A, Alouch S, Chawla Y, Gonsalves W
Blood Lymphat Cancer. 2024; 14:71-87.
PMID: 39664714
PMC: 11631777.
DOI: 10.2147/BLCTT.S490021.
Chen Y, Chen M, Liu Y, Li Q, Xue Y, Liu L
JCI Insight. 2024; 9(21).
PMID: 39325665
PMC: 11601555.
DOI: 10.1172/jci.insight.183400.
Stohl W, Wu Y, Stohl M
ACR Open Rheumatol. 2024; 6(11):756-768.
PMID: 39143363
PMC: 11557988.
DOI: 10.1002/acr2.11712.
Garcia-Carmona Y, Fribourg M, Sowa A, Cerutti A, Cunningham-Rundles C
Clin Immunol. 2023; 253:109689.
PMID: 37422057
PMC: 10528899.
DOI: 10.1016/j.clim.2023.109689.
Xing L, Liu Y, Liu J
Cancers (Basel). 2023; 15(8).
PMID: 37190168
PMC: 10137208.
DOI: 10.3390/cancers15082240.
In good times and in bad: How plasma cells resolve stress for a life-long union with the bone marrow.
Ulbricht C, Cao Y, Niesner R, Hauser A
Front Immunol. 2023; 14:1112922.
PMID: 37033993
PMC: 10080396.
DOI: 10.3389/fimmu.2023.1112922.
Dual Role of B Cells in Multiple Sclerosis.
Kumar G, Axtell R
Int J Mol Sci. 2023; 24(3).
PMID: 36768658
PMC: 9916779.
DOI: 10.3390/ijms24032336.
Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI.
Ramirez N, Posadas-Cantera S, Langer N, de Oteyza A, Proietti M, Keller B
Front Immunol. 2022; 13:938240.
PMID: 36072607
PMC: 9443529.
DOI: 10.3389/fimmu.2022.938240.
Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation.
Jiang Y, Sun J, Wei J
J Mol Model. 2022; 28(10):292.
PMID: 36063219
DOI: 10.1007/s00894-022-05142-7.
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma.
Miao Y, Thakkar K, Cenik C, Jiang D, Mizuno K, Jia C
J Exp Med. 2022; 219(9).
PMID: 35881112
PMC: 9428257.
DOI: 10.1084/jem.20220214.
Gene cascade analysis in human granulosa tumor cells (KGN) following exposure to high levels of free fatty acids and insulin.
Tremblay P, Fortin C, Sirard M
J Ovarian Res. 2021; 14(1):178.
PMID: 34930403
PMC: 8690403.
DOI: 10.1186/s13048-021-00934-6.
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.
Bhalla S, Melnekoff D, Aleman A, Leshchenko V, Restrepo P, Keats J
Sci Adv. 2021; 7(47):eabg9551.
PMID: 34788103
PMC: 8598000.
DOI: 10.1126/sciadv.abg9551.
Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators.
Nguyen D, Duan M, Ali M, Ley A, Sanz I, Lee F
Immunol Rev. 2021; 303(1):138-153.
PMID: 34337772
PMC: 8387437.
DOI: 10.1111/imr.13013.
Telitacicept Following Plasma Exchange in the Treatment of Subjects With Recurrent NMOSD: Study Protocol for a Single-Center, Single-Arm, Open-Label Study.
Ding J, Cai Y, Deng Y, Jiang X, Gao M, Lin Y
Front Neurol. 2021; 12:596791.
PMID: 33868140
PMC: 8044936.
DOI: 10.3389/fneur.2021.596791.
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS.
Kumar G, Maria Z, Kohli U, Agasing A, Quinn J, Ko R
Neurol Neuroimmunol Neuroinflamm. 2021; 8(3).
PMID: 33649164
PMC: 7954465.
DOI: 10.1212/NXI.0000000000000973.
Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia.
Hao Y, Bi H, Li H, Yin L, Yu J, Tao W
J Immunol Res. 2021; 2021:3676942.
PMID: 33564689
PMC: 7867467.
DOI: 10.1155/2021/3676942.
B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps.
Wang Z, Song J, Wang H, Li J, Xiao Q, Yu Z
Front Immunol. 2021; 11:625630.
PMID: 33552090
PMC: 7854540.
DOI: 10.3389/fimmu.2020.625630.
Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies.
Lin W, Wang H, Chen Y, Lin C, Fan H, Lee Y
Int J Mol Sci. 2020; 21(22).
PMID: 33212810
PMC: 7697548.
DOI: 10.3390/ijms21228655.
Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.
Pillarisetti K, Powers G, Luistro L, Babich A, Baldwin E, Li Y
Blood Adv. 2020; 4(18):4538-4549.
PMID: 32956453
PMC: 7509877.
DOI: 10.1182/bloodadvances.2020002393.
BCMA-targeted immunotherapy for multiple myeloma.
Yu B, Jiang T, Liu D
J Hematol Oncol. 2020; 13(1):125.
PMID: 32943087
PMC: 7499842.
DOI: 10.1186/s13045-020-00962-7.